跳至主要内容
临床试验/NCT00350506
NCT00350506终止不适用

An Open-label, Non-randomized, Multi-center Trial Evaluating the Clinical Applicability, Correlation, and Modeling of Cardiac CT Using 64 Detector Row VCT

GE Healthcare2 个研究点 分布在 1 个国家目标入组 77 人开始时间: 2005年10月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
GE Healthcare
入组人数
77
试验地点
2

研究概览

简要总结

To compare computed tomography (CT) images (pictures) of the coronary arteries using the General Electric (GE) LightSpeed VCT scanner with x-ray coronary angiography in patients referred for an x-ray coronary angiography.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for elective diagnostic catheterization OR
  • Elective diagnostic catheterization has been performed within the past 2 weeks but no less than 24 hours prior to the coronary CTA procedure with no intervention performed or change of the patient clinical status.
  • Age ≥18 years but ≤75 years.

排除标准

  • Prior coronary stent implantation
  • Prior coronary artery bypass grafting or other heart surgery
  • Prior pacemaker or internal defibrillator lead implantation
  • Prior artificial heart valve
  • Biochemical renal insufficiency (CrSerum > 1.6) or on dialysis
  • Resting HR > 100 at the time of enrollment
  • Contraindication to β-blockade or calcium channel blocker
  • High-grade atrioventricular (AV) block
  • Systolic blood pressure <90 mm Hg
  • Severe asthma or active bronchospasm and/or chronic obstructive pulmonary disease
  • Atrial fibrillation
  • Inability to provide informed consent
  • Evidence of ongoing or active clinical instability
  • Acute chest pain (sudden onset)
  • Acute myocardial infarction
  • Cardiac shock
  • Acute pulmonary edema

研究组 & 干预措施

64 Channel VCT

Experimental

All subjects underwent Coronary Computed Tomographic Angiography (CCTA) after receiving an intravenous (IV) administration of Visipaque (320 mgI/mL), to be followed by catheter coronary angiography (CATH).

干预措施: 64 Channel VCT (Device)

研究者

发起方
GE Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验